≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Lumbosacral root disorders, not elsewhere classified

DOID EFO Endpoint Browser PheWeb

G6_LSROOT

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G54.4
  • Hospital discharge: ICD-9 — 3534
  • Cause of death: ICD-10 — G54.4
  • Cause of death: ICD-9 — 3534

2 out of 7 registries used, show all original rules.

440

4. Check minimum number of events

None

440

5. Include endpoints

None

440

6. Filter based on genotype QC (FinnGen only)

440

Control definitions (FinnGen only)

Control exclude
G6_NERPLEX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G54
Name in latin
Morbositates radicum nervorum lumbosacralium non alibi classificatae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3586 1888 1683
Only index persons 3295 1778 1517
Unadjusted period prevalence (%)
Whole population 0.05 0.05 0.05
Only index persons 0.06 0.07 0.06
Median age at first event (years)
Whole population 57.09 56.62 57.51
Only index persons 56.44 55.99 56.96

-FinnGen-

Key figures

All Female Male
Number of individuals 440 252 188
Unadjusted period prevalence (%) 0.08 0.09 0.08
Median age at first event (years) 54.68 52.13 58.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
408
Matched controls
4079
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G54.4
ICD-10 Finland
Lumbosacral root disorders, not elsewhere classified
+∞
323.0
335
*
XA402
NOMESCO Finland
ENMG
200.6
233.2
226
25
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
10.2
77.4
177
285
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
8.2
73.2
202
435
N03AX16
ATC
pregabalin; oral
7.6
72.9
222
553
3534A
ICD-9 Finland
Nerve root and plexus disorders, Lumbosacral root lesions, not elsewhere classified[RADICULOPATHIA LUMBOSACRALIS]
+∞
68.7
64
*
M48.0
ICD-10 Finland
Spinal stenosis
8.1
53.4
135
234
N03AX12
ATC
gabapentin; oral
7.1
52.7
150
309
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
7.9
51.3
131
229
M54.4
ICD-10 Finland
Lumbago with sciatica
6.1
46.7
150
354
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
488.3
45.2
44
*
M54.5
ICD-10 Finland
Low back pain
4.6
43.9
214
790
M54.1
ICD-10 Finland
Radiculopathy
14.9
40.9
70
56
N02AX02
ATC
tramadol; systemic, rectal
3.8
35.7
244
1148
G56.0
ICD-10 Finland
Carpal tunnel syndrome
17.0
34.2
55
37
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
65.5
31.6
36
6
Z01.9
ICD-10 Finland
Special examination, unspecified
8.1
30.8
73
107
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
8.3
30.5
71
101
ACC51
NOMESCO Finland
Release of median nerve
325.2
30.2
30
*
N06AA09
ATC
amitriptyline; systemic
5.3
26.8
89
203
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
12.2
26.7
49
45
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
8.7
26.4
59
78
N02AA05
ATC
oxycodone; systemic
4.3
26.1
109
316
L03
ICPC
Low back symptom/complaint
3.5
24.6
144
552
N06AX21
ATC
duloxetine; oral
5.2
23.8
80
184
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
5.6
23.1
71
147
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.9
22.5
230
1271
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
31.1
22.2
29
10
M79.6
ICD-10 Finland
Pain in limb
2.8
20.0
181
910
M01AH05
ATC
etoricoxib; oral
2.7
19.8
283
1851
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
20.7
19.8
29
15
Z50.1
ICD-10 Finland
Other physical therapy
6.1
19.6
55
101
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
4.6
19.3
72
183
M17.1
ICD-10 Finland
Other primary gonarthrosis
3.1
19.0
127
521
A02BC03
ATC
lansoprazole; oral
2.8
18.8
165
804
M54.9
ICD-10 Finland
Dorsalgia, unspecified
4.1
18.5
77
217
A02BC05
ATC
esomeprazole; systemic
2.6
18.3
208
1174
L28
ICPC
Limited function/disability (L)
3.5
18.1
96
330
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.8
17.9
82
252
N02AJ06
ATC
codeine and paracetamol; systemic
2.6
17.6
181
961
M03BC01
ATC
orphenadrine (citrate); systemic
2.9
17.3
127
550
M03BX02
ATC
tizanidine; oral
2.5
17.0
278
1878
M01AB05
ATC
diclofenac; systemic, rectal
2.6
16.9
301
2125
M43.1
ICD-10 Finland
Spondylolisthesis
6.5
16.7
44
74
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.2
16.7
67
182
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
8.3
16.2
36
47
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
7.3
16.2
39
58
A29
ICPC
General symptom/complaint other
3.6
16.1
78
250
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
16.0
169
897
M01AC06
ATC
meloxicam; systemic, rectal
2.4
15.6
183
1023
M47.9
ICD-10 Finland
Spondylosis, unspecified
9.3
15.5
32
37
A02BC02
ATC
pantoprazole; systemic
2.5
15.5
298
2132
WX702
NOMESCO Finland
Supraglottic ventilation device
5.4
15.2
46
93
R29
ICPC
Respiratory symptom/complaint other
5.4
15.2
46
93
M01AH01
ATC
celecoxib; oral (coxibs)
2.8
15.0
110
471
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
83.1
14.7
16
*
N06AX16
ATC
venlafaxine; oral
3.3
14.6
79
273
XA420
NOMESCO Finland
Extensive sleep examination
15.1
14.2
23
16
Z00.6
ICD-10 Finland
Examination for normal comparison and control in clinical research programme
9.9
14.2
28
30
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.6
13.7
40
77
N02BE01
ATC
paracetamol; systemic, rectal
3.1
13.7
365
2995
S02.5
ICD-10 Finland
Fracture of tooth
8.2
13.6
30
39
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
3.9
13.4
57
163
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
41.5
13.2
16
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.6
13.0
46
110
M25.5
ICD-10 Finland
Pain in joint
2.4
12.7
132
678
XG410
NOMESCO Finland
Flow-volume spirometry
5.7
12.6
36
68
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
6.1
12.5
34
60
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.9
12.5
81
317
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
27.7
12.1
16
6
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.4
12.1
117
577
L15
ICPC
Knee symptom/complaint
2.6
12.1
97
433
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
12.0
139
749
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
8.8
12.0
25
30
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
48.1
11.9
14
*
M54.3
ICD-10 Finland
Sciatica
4.6
11.8
41
97
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.3
11.6
61
207
R1280
NOMESCO Finland
Evaluation of the need for vocational rehabilitation
+∞
11.5
11
*
L29
ICPC
Musculoskeletal sympt/complt other
3.9
11.5
48
135
A06AD11
ATC
lactulose; oral
2.8
11.3
81
335
KMAK
NOMESCO Finland
NA
2.1
11.3
214
1421
M01AE02
ATC
naproxen; oral, rectal
2.1
11.3
248
1751
J01DB01
ATC
cefalexin; oral
2.4
11.2
339
2742
S59
ICPC
Skin, Other therap proced/minor surg NEC
13.2
11.2
19
15
M01AX05
ATC
glucosamine; oral
2.4
11.2
106
514
M01AH02
ATC
rofecoxib; oral
2.9
11.1
74
293
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
11.0
129
693
NG1EA
SPAT
NA
44.6
11.0
13
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.6
10.9
90
405
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
10.0
10.9
21
22
S02.51
ICD-10 Finland
Fracture of tooth, open
3.1
10.8
61
217
ZXA00
NOMESCO Finland
Right side
2.2
10.7
128
694
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
6.9
10.7
26
40
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.9
10.6
29
52
K29
ICPC
Cardiovascular sympt/complt other
5.3
10.6
32
65
K30
ICD-10 Finland
Functional dyspepsia
3.0
10.4
63
235
9211
FHL
Exploration or removal of diskusprolapse
6.9
10.4
25
38
GD1AA
SPAT
NA
3.9
10.3
43
121
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.9
10.3
66
255
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
10.3
133
744
ZXA05
NOMESCO Finland
Left side
2.2
10.2
121
651
A28
ICPC
Limited function/disability NOS
2.6
10.1
77
330
S29
ICPC
Skin symptom/complaint other
2.5
10.0
82
367
R43
ICPC
Respiratory, Other diagnostic procedure
17.2
9.9
15
9
M01AE01
ATC
ibuprofen; systemic, rectal
2.7
9.9
366
3127
G54.0
ICD-10 Finland
Brachial plexus disorders
26.8
9.9
13
5
J45.9
ICD-10 Finland
Asthma, unspecified
2.5
9.8
86
400
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
9.7
59
219
H02AB06
ATC
prednisolone; systemic
1.9
9.6
204
1383
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
18.1
9.5
14
8
ABC99
NOMESCO Finland
Other decompressive operation on spinal cord or nerve root
30.8
9.4
12
*
3534B
ICD-9 Finland
Nerve root and plexus disorders, Lumbosacral root lesions, not elsewhere classified[SYNDROMA CAUDAE EQUINAE]
+∞
9.4
9
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
9.3
168
1070
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
9.2
197
1331
G56.2
ICD-10 Finland
Lesion of ulnar nerve
16.0
9.1
14
9
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
16.0
9.1
14
9
J01FA09
ATC
clarithromycin; systemic
2.0
9.0
145
880
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.9
9.0
211
1473
M01AX17
ATC
nimesulide; oral
2.1
9.0
116
644
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
5.4
8.9
26
51
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
8.9
50
176
Z02.7
ICD-10 Finland
Issue of medical certificate
3.8
8.9
37
104
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
5.6
8.9
25
47
M47.82
ICD-10 Finland
Other spondylosis, cervical region
4.5
8.8
30
70
M70.6
ICD-10 Finland
Trochanteric bursitis
2.7
8.6
63
262
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.5
8.6
40
124
M01AE11
ATC
tiaprofenic acid; oral, rectal
4.1
8.6
32
82
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.7
8.5
28
63
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
6.5
8.4
21
34
35399
ICD-8 Finland
Sciatica
+∞
8.4
8
*
G54.2
ICD-10 Finland
Cervical root disorders, not elsewhere classified
+∞
8.4
8
*
R52.2
ICD-10 Finland
Other chronic pain
5.6
8.3
23
43
R96
ICPC
Asthma
3.1
8.3
44
151
WX704
NOMESCO Finland
Intubation
3.2
8.2
42
140
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.5
8.2
64
278
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.9
8.2
33
91
TAB20
NOMESCO Finland
Epidural puncture
17.6
8.1
12
7
B01AB10
ATC
tinzaparin; parenteral
3.1
8.1
45
156
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
7.5
8.0
18
25
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.1
8.0
105
583
S18
ICPC
Laceration/cut
1.9
7.9
170
1133
WZA90
NOMESCO Finland
Other doctors statement
2.1
7.9
100
547
H57.1
ICD-10 Finland
Ocular pain
5.5
7.8
22
42
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
6.1
7.8
20
34
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
7.8
66
297
JN3AE
SPAT
NA
7.7
7.7
17
23
UKC02
NOMESCO Finland
Cystoscopy
2.3
7.7
77
378
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
7.6
271
2123
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
7.6
127
773
S06.0
ICD-10 Finland
Concussion
2.8
7.5
50
197
R51.80
ICD-10 Finland
Headache
2.4
7.4
62
278
XG412
SPAT
NA
81.5
7.4
8
*
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
81.5
7.4
8
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
7.4
53
217
G51.0
ICD-10 Finland
Bell palsy
+∞
7.3
7
*
N05CD07
ATC
temazepam; oral
2.4
7.3
64
296
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
7.3
63
287
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
7.5
7.3
16
22
N03AX09
ATC
lamotrigine; oral
4.3
7.1
25
61
G45.4
ICD-10 Finland
Transient global amnesia
5.3
7.0
20
39
P03
ICPC
Feeling depressed
3.1
7.0
37
127
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.3
7.0
64
301
J01DA01
ATC
[U] cefalexin; systemic
1.8
7.0
254
1975
R05
ICPC
Cough
2.0
6.9
94
527
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
14.1
6.9
11
8
NE1AA
SPAT
NA
14.1
6.9
11
8
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
6.9
56
247
N05CF01
ATC
zopiclone; oral
1.8
6.9
138
888
Z98.8
ICD-10 Finland
Other specified postsurgical states
9.5
6.8
13
14
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
4.9
6.8
21
45
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
6.8
58
263
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
40.7
6.8
8
*
R52.1
ICD-10 Finland
Chronic intractable pain
17.0
6.8
10
6
UJF32
NOMESCO Finland
Coloscopy
1.9
6.8
112
675
M54.6
ICD-10 Finland
Pain in thoracic spine
3.3
6.7
32
102
N03AE01
ATC
clonazepam; systemic
3.3
6.7
32
102
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.4
6.7
23
55
RTGOM
NOMESCO Finland
NA
22.9
6.7
9
*
J01MA02
ATC
ciprofloxacin; systemic
1.8
6.7
164
1129
P01
ICPC
Feeling anxious/nervous/tense
3.2
6.6
33
109
B01AX05
ATC
fondaparinux; parenteral
12.5
6.6
11
9
K02.1
ICD-10 Finland
Caries of dentine
1.7
6.6
214
1596
ND2AA
SPAT
NA
5.2
6.6
19
38
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
2.9
6.5
38
139
R5140
NOMESCO Finland
Monitoring the use of the aid
2.5
6.5
53
234
P01AB01
ATC
metronidazole; oral, rectal
1.7
6.4
162
1116
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
3.3
6.4
31
100
J01CA04
ATC
amoxicillin; systemic
1.8
6.4
316
2662
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.7
6.4
219
1652
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
6.7
6.4
15
23
M24.2
ICD-10 Finland
Disorder of ligament
8.3
6.4
13
16
M50.3
ICD-10 Finland
Other cervical disc degeneration
5.7
6.4
17
31
D29
ICPC
Digestive symptom/complaint other
6.1
6.4
16
27
XF404
NOMESCO Finland
Ambulatory ECG
2.6
6.3
47
198
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.0
6.3
87
487
G55.2
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
+∞
6.3
6
*
L86
ICPC
Back syndrome with radiating pain
3.4
6.3
29
91
WX110
NOMESCO Finland
Local anesthesy
1.7
6.3
261
2082
M02AA07
ATC
piroxicam; topical
1.7
6.1
152
1041
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.9
6.1
36
133
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
6.1
81
449
SFA00
NOMESCO Finland
Small filling
2.3
6.1
54
251
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.7
6.1
39
152
R07.3
ICD-10 Finland
Other chest pain
2.5
6.0
46
198
L13
ICPC
Hip symptom/complaint
2.1
6.0
65
331
C07AB07
ATC
bisoprolol; oral
1.7
6.0
190
1395

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014051) Protein [Presence] in Urine by Test strip
54
63
9.63
43.53
1.9
2.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
137
459
3.88
35.27
12.6
21.1
inr
1.0
1.3
—
6
62
(3045414) Leukocytes [Presence] in Urine
64
135
5.38
29.55
1.9
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
184
923
2.71
22.23
8.3
6.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
102
391
3.09
20.14
3.7
2.7
umol/l
8.0
9.9
0.32
94
341
(3022621) pH of Urine by Test strip
68
211
3.63
18.80
2.3
2.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
58
166
3.87
18.01
2.0
3.5
—
—
—
0
0
(4024509)
22
27
8.52
16.77
1.6
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
245
1606
2.19
14.36
5.3
5.5
mmol/l
1.2
1.2
0.04
228
1452
(3013826) Glucose [Moles/volume] in Serum or Plasma
287
2068
2.12
12.36
4.9
4.4
mmol/l
6.7
6.7
0.06
278
1941
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
212
1375
2.05
12.09
4.3
3.4
ng/l
27.3
34.6
0.80
175
963
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
59
223
2.90
11.64
2.0
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
251
1760
1.99
11.18
5.5
6.6
mmol/l
1.2
1.2
0.00
229
1493
(3018418) pH of Serum or Plasma
174
1078
2.02
11.02
4.0
3.7
ph
7.4
7.4
0.21
11
213
(3013707) Erythrocyte sedimentation rate by Westergren method
332
2637
2.06
9.59
4.7
3.9
mm/h
11.5
12.4
0.73
317
2413
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
51
201
2.74
9.27
1.7
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
108
599
2.06
9.03
1.4
1.2
iu/ml
17.4
36.6
2.29
42
194
(3014111) Lactate [Moles/volume] in Serum or Plasma
68
313
2.39
8.98
5.5
6.6
mmol/l
1.2
1.3
0.20
68
298
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
79
396
2.21
8.53
2.0
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
79
401
2.18
8.26
2.0
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
112
651
1.97
8.13
3.2
3.8
ng/l
524.2
261.3
0.54
79
509
(3018010) Neutrophils/100 leukocytes in Blood
228
1657
1.78
8.06
5.6
5.7
%
56.9
57.3
0.26
219
1544
(3002030) Lymphocytes/100 leukocytes in Blood
227
1668
1.75
7.56
5.7
6.0
%
27.9
27.4
0.32
220
1544
(3006504) Eosinophils/100 leukocytes in Blood
223
1632
1.74
7.52
5.7
5.8
%
3.0
2.8
1.32
214
1511
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
98
559
1.97
7.45
1.3
1.2
u/ml
14.7
13.9
0.03
28
224
(3001604) Monocytes [#/volume] in Blood
233
1736
1.73
7.29
5.6
5.6
e9/l
0.6
0.6
0.14
216
1487
(3019069) Monocytes/100 leukocytes in Blood
223
1643
1.72
7.25
6.2
6.1
%
8.7
8.8
0.27
216
1532
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
15
30
5.14
7.23
1.0
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
237
1777
1.72
7.22
5.6
5.6
e9/l
1.8
1.9
0.46
220
1554
(3013115) Eosinophils [#/volume] in Blood
239
1800
1.72
7.13
6.0
6.0
e9/l
0.2
0.2
0.74
222
1574
(3006315) Basophils [#/volume] in Blood
233
1746
1.71
7.05
5.6
5.6
e9/l
0.0
0.0
0.78
216
1496
(3022096) Basophils/100 leukocytes in Blood
216
1586
1.71
7.04
5.5
5.8
%
0.7
0.7
0.35
209
1468
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
54
1028
0.46
6.85
2.0
1.6
mmol/l
1.5
1.4
0.39
44
857
(40768797) Stomach Pathology biopsy report
85
475
1.98
6.82
1.2
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
25
78
3.34
6.80
1.4
2.9
kpa
7.7
8.0
0.45
25
72
(3003396) Base excess in Arterial blood by calculation
72
384
2.05
6.57
5.8
7.8
mmol/l
1.7
1.3
0.38
55
303
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
96
566
1.89
6.56
2.0
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
217
1620
1.67
6.47
3.9
4.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
165
1149
1.70
6.39
5.6
5.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
133
880
1.73
6.17
3.8
3.8
%
94.6
92.2
0.47
127
859
(3003338) MCHC [Mass/volume]
350
2995
1.82
6.05
23.2
18.0
g/l
331.3
332.2
1.16
350
2972
(3031040) Bacteria [#/volume] in Urine by Automated count
284
2303
1.66
5.89
4.9
4.2
e6/l
9.6
2588.8
—
5
45
(3037522) Nuclear Ab [Titer] in Serum
77
443
1.89
5.63
1.2
1.3
titre
411.4
534.5
0.40
14
94
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
117
2.68
5.59
2.5
2.1
g/l
3.0
3.0
0.07
22
89
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
26
4.72
5.29
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
26
4.72
5.29
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
26
4.72
5.29
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
151
1070
1.63
5.27
3.6
2.9
ng/l
2186.9
1142.8
0.49
133
925
(3009542) Hematocrit [Volume Fraction] of Blood
366
3223
1.81
5.13
20.4
14.9
%
40.0
39.8
0.25
298
2298
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
27
4.54
5.06
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
27
4.54
5.06
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
27
4.54
5.06
1.1
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
392
3531
2.01
5.06
19.4
13.9
mg/l
21.9
23.7
0.46
347
2767
(3017732) Neutrophils [#/volume] in Blood
48
243
2.09
5.02
3.5
3.2
e9/l
4.5
4.1
0.54
43
189
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
237
1884
1.56
4.97
5.6
6.6
umol/l
11.7
11.4
0.07
224
1788
(3013650) Neutrophils [#/volume] in Blood by Automated count
255
2061
1.56
4.96
8.6
9.5
e9/l
4.5
4.0
0.37
237
1787
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
21
72
3.01
4.94
1.1
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
326
2793
1.65
4.93
7.9
7.6
u/l
78.3
78.5
0.03
311
2614
(3011397) Hemoglobin [Presence] in Urine by Test strip
117
790
1.66
4.89
3.1
3.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
135
948
1.61
4.82
4.4
4.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
127
2.46
4.76
2.5
2.0
g/l
3.9
3.8
0.11
21
88
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
127
2.46
4.76
2.5
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
127
2.46
4.76
2.5
2.0
g/l
7.0
7.2
0.17
23
92
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
152
1101
1.58
4.75
2.7
2.4
u/l
49.7
57.5
2.58
146
1020
(3044889) 12 lead EKG panel
309
2624
1.60
4.74
4.0
3.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
290
2427
1.57
4.73
4.3
4.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
42
208
2.13
4.65
2.9
3.2
mmol/l
2.1
1.9
0.17
31
163
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
25
98
2.64
4.63
1.2
1.2
—
3.3
—
0
5
(40768804) Tissue Pathology biopsy report
192
1476
1.53
4.56
2.0
2.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
88
564
1.70
4.45
3.0
2.8
e6/l
1.0
2.3
2.64
73
299
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
91
590
1.68
4.41
3.0
2.6
e6/l
1.1
1.0
0.01
76
323
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
145
1057
1.55
4.34
1.9
2.1
u/l
251.3
188.2
0.38
137
992
(1761868) Lipid panel - Serum or Plasma
96
1373
0.62
4.25
2.5
2.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
104
2.49
4.13
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
321
0.30
3.98
1.3
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
38
194
2.05
3.91
1.3
1.3
—
28.3
—
0
11
(3021589) Normoblasts [#/volume] in Blood
201
1598
1.47
3.88
8.4
9.2
e9/l
0.2
0.0
0.49
182
1312
(3003694) ABO and Rh group [Type] in Blood
123
889
1.53
3.75
1.3
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
51
3.01
3.61
1.5
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
401
3719
1.88
3.58
16.4
13.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
185
1467
1.45
3.53
2.1
1.9
pmol/l
93.4
95.3
0.24
101
757
(3024263) Appearance of Synovial fluid
9
17
5.38
3.52
1.7
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
42
232
1.90
3.48
2.1
2.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
24
109
2.27
3.32
2.7
2.3
g/l
0.9
1.4
0.24
24
95
(3026008) Bacteria identified in Urine by Culture
140
1063
1.46
3.31
2.8
2.9
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
22
97
2.33
3.25
2.8
2.2
g/l
0.0
0.0
0.00
22
90
(3021960) Folate [Moles/volume] in Serum or Plasma
115
849
1.48
3.11
1.5
1.5
nmol/l
22.6
20.9
0.51
101
720
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
71
472
1.60
3.09
2.0
2.3
%
23.7
23.7
0.00
60
407
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
18
74
2.49
3.09
1.1
1.2
—
17.6
—
0
8
(3022948) Iron [Moles/volume] in Serum or Plasma
79
539
1.57
3.08
2.1
2.3
umol/l
14.0
13.5
0.21
68
499
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
377
3470
1.60
3.04
16.0
13.0
ml/min/173m2
79.9
79.0
0.40
335
2870
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
181
1461
1.41
3.01
2.1
2.3
nmol/l
76.9
77.9
0.20
169
1307
(36304419) Bacteria [Presence] in Urine
125
944
1.45
3.00
3.2
2.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
42
244
1.80
2.99
1.6
1.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
20
89
2.31
2.91
2.7
2.2
g/l
0.0
0.0
0.00
20
83
(3004789) Transferrin [Mass/volume] in Serum or Plasma
74
504
1.56
2.91
2.0
2.2
g/l
2.3
2.3
0.13
68
468
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
20
90
2.28
2.84
2.7
2.2
g/l
0.0
0.0
0.00
20
83
(3021901) Oxygen saturation in Capillary blood
16
66
2.48
2.74
1.1
2.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
406
3830
1.78
2.70
21.1
16.4
umol/l
76.9
77.1
0.03
406
3830
(3026493) Urate [Moles/volume] in Serum or Plasma
119
910
1.42
2.64
2.1
2.6
umol/l
347.3
7729.6
3.84
109
774
(3002582) Erythrocytes [#/volume] in Urine
137
1078
1.39
2.57
3.2
3.0
e6/l
37.6
130.7
0.84
128
825
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
18
81
2.27
2.57
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
358
3292
1.47
2.54
5.1
4.6
mu/l
1.8
2.3
0.73
339
2986
(3030467) Casts [#/volume] in Urine by Automated count
125
975
1.39
2.46
3.2
3.0
e6/l
0.2
0.5
1.87
116
723
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
112
860
1.41
2.41
1.9
1.9
mg/l
3.0
2.9
0.04
102
736
(3018095) Leukocytes [#/volume] in Urine
155
1258
1.36
2.38
3.4
3.6
e6/l
82.2
73.8
0.08
137
901
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
50
328
1.59
2.32
2.8
2.3
u/l
33.4
33.2
0.01
36
273
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
179
1.79
2.29
2.0
2.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
9
5.60
2.22
1.0
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
13
54
2.45
2.22
1.1
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
24
3.38
2.19
1.5
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
15
4.04
2.04
1.0
1.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
75
553
1.43
2.02
2.1
1.8
s
30.4
29.5
0.79
75
535
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
57
2.32
1.99
1.5
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
13
58
2.28
1.92
1.5
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
27
160
1.73
1.86
3.8
3.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
10
220
0.44
1.84
2.4
3.0
g/l
123.9
128.4
—
10
214
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
12
4.20
1.83
1.0
1.1
iu/ml
143.6
110.8
—
5
12
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
300
2739
1.30
1.79
4.6
3.8
pmol/l
14.8
14.8
0.08
287
2465
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
47
2.37
1.79
1.1
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
98
773
1.34
1.77
1.8
1.7
mg/l
1.4
1.3
0.06
77
618
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
18
3.36
1.75
1.2
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
18
3.36
1.75
1.2
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
146
0.40
1.67
1.5
1.8
mg/l
2.6
2.7
—
6
112
(3016018) Differential panel - Cerebral spinal fluid
7
25
2.83
1.65
1.9
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
54
390
1.44
1.64
1.7
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
19
106
1.83
1.61
1.4
1.7
iu/ml
0.0
0.1
—
6
19
(40760888) Immunoglobulin light chains.free panel - Serum
15
77
1.98
1.61
2.7
4.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
32
2.53
1.60
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
225
1.55
1.57
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
177
1.62
1.56
9.0
10.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
402
3859
1.48
1.53
11.5
10.4
u/l
26.4
25.7
0.38
393
3725
(3041096) Erythrocytes [Presence] in Urine by Automated
78
983
0.75
1.52
3.4
3.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
52
379
1.42
1.51
1.3
1.6
%
1.4
1.5
0.66
44
328
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
326
0.60
1.47
1.8
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
45
2.25
1.47
1.7
3.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
169
1469
1.24
1.42
2.9
2.5
ug/l
114.4
130.9
0.53
161
1349
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
31
449
0.67
1.37
5.3
4.4
%
34.7
31.9
0.76
20
298
(3023511) Choriogonadotropin [Units/volume] in Urine
6
23
2.63
1.37
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
47
2.15
1.34
1.0
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
113
1.71
1.34
2.3
2.5
u/ml
0.4
0.4
0.03
13
58
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
54
2.06
1.34
1.2
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
78
963
0.77
1.30
3.4
4.2
%
17.3
21.3
2.00
32
473
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
19
303
0.61
1.30
5.8
3.4
mmol/l
1.2
1.2
0.18
14
267
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
19
114
1.70
1.30
1.2
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
217
0.54
1.30
1.3
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
410
3971
1.48
1.26
25.7
20.5
e12/l
4.4
4.5
2.48
405
3849
(3010813) Leukocytes [#/volume] in Blood
410
3971
1.48
1.26
25.7
20.5
e9/l
7.4
6.6
0.79
405
3846
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
225
2035
1.22
1.25
2.8
2.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
101
840
1.26
1.23
2.2
2.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
56
1.99
1.23
1.1
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
19
2.65
1.22
1.4
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
194
1738
1.21
1.17
3.4
3.5
estimate
0.0
0.0
0.00
28
323
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
87
1.75
1.16
1.6
1.7
iu/l
6.0
6.4
—
6
32
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
34
0.00
1.16
0.0
2.9
—
54.2
—
0
25
(3026389) Candida sp identified in Specimen by Organism specific culture
8
39
2.07
1.16
1.0
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
63
497
1.31
1.15
2.3
1.9
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
20
2.52
1.15
1.6
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
130
1121
1.23
1.14
2.2
2.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
14
80
1.77
1.14
1.9
1.2
mg/l
354.6
464.1
1.23
14
74
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
104
1.66
1.11
3.2
3.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
14
82
1.73
1.06
2.3
1.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
30
213
1.44
1.05
1.7
2.7
e6/l
0.4
0.2
0.51
30
205
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
46
1.98
1.04
2.7
3.5
—
—
—
0
0
(4010399)
17
262
0.63
1.04
1.5
1.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
22
2.29
1.03
1.8
2.4
ug/l
2.3
2.2
—
5
17
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
34
2.08
1.03
2.4
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
56
698
0.77
1.01
2.1
2.9
ug/l
0.6
0.7
1.05
34
467
(3045788) Cell count panel - Pleural fluid
7
35
2.02
1.00
1.6
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
372
3574
1.26
1.00
4.6
4.6
mmol/l
6.0
6.0
0.06
351
3257
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
49
1.85
0.99
1.1
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
87
731
1.24
0.98
2.3
2.5
e6/l
5.9
5.1
0.18
78
648
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
62
758
0.79
0.97
1.6
1.7
pmol/l
424.3
16207886.8
0.78
49
617
(3029937) Albumin [Presence] in Urine by Test strip
81
960
0.81
0.96
4.6
3.8
estimate
0.0
0.0
0.00
25
316
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
77
1.71
0.96
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
85
1.67
0.95
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
85
1.67
0.95
1.1
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
62
1.79
0.95
1.5
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
63
1.77
0.91
1.1
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
193
1760
1.17
0.89
4.2
4.7
estimate
0.0
0.0
0.00
29
325
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
56
1.80
0.88
1.2
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
56
1.80
0.88
1.1
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
43
1.88
0.87
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
44
1.83
0.86
1.3
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
66
789
0.81
0.85
3.6
4.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
31
1.95
0.84
2.8
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
56
456
1.26
0.84
3.8
5.4
mmol/l
1.1
1.0
0.34
56
416
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
85
726
1.21
0.83
1.2
1.2
u/ml
0.5
1.7
2.88
12
212
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
133
1185
1.18
0.81
4.2
4.8
ug/l
1.7
2.5
1.96
122
1060
(3020779) Urea [Moles/volume] in Serum or Plasma
37
287
1.32
0.80
5.2
7.3
mmol/l
10.8
9.9
0.31
37
268
(3001019) Free T4 and TSH panel - Serum or Plasma
11
175
0.62
0.80
2.7
1.8
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
24
0.00
0.79
0.0
1.5
—
0.7
—
0
10
(3005570) Glucose [Moles/volume] in Urine
6
33
1.83
0.79
1.7
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
33
1.83
0.79
2.0
2.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
26
0.00
0.78
0.0
3.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
125
0.55
0.78
1.1
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
34
1.78
0.76
1.3
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
28
0.00
0.76
0.0
1.1
—
416.2
—
0
23
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
91
1.56
0.76
1.1
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
193
1780
1.15
0.74
3.4
3.5
estimate
0.0
0.0
0.80
27
317
(3019150) Specific gravity of Urine by Refractometry
88
763
1.19
0.74
3.9
3.8
kg/l
1.0
1.0
0.98
12
91
(3004616) Nuclear Ab [Presence] in Serum
7
38
1.86
0.74
1.6
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
25
2.01
0.73
1.2
1.1
mg/l
29.8
31.0
—
5
20
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
17
117
1.47
0.73
2.3
2.1
ug/l
180.8
272.2
0.59
17
111
(3024561) Albumin [Mass/volume] in Serum or Plasma
168
1539
1.15
0.70
4.6
4.8
g/l
34.3
35.5
1.73
160
1433
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
213
1.34
0.70
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
77
1.57
0.69
1.1
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
42
1.68
0.68
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.2
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
29
1.73
0.64
2.8
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
10
153
0.65
0.64
1.2
1.5
—
—
—
0
0
(3000492) Spirometry study
27
345
0.77
0.63
1.6
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
49
1.64
0.62
1.1
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
0
20
0.00
0.60
0.0
2.3
—
494.4
—
0
14
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
220
0.72
0.60
1.6
1.6
—
—
—
0
0
(3013512) EKG study
98
1094
0.87
0.60
3.1
3.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
14
97
1.46
0.59
1.3
1.3
iu/l
40.1
35.6
0.18
14
84
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
64
1.58
0.59
1.2
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
113
0.61
0.59
1.4
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
15.7
—
828.4
—
0
23
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
21.8
—
1672.6
—
0
23
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
126
1379
0.88
0.58
3.9
3.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.0
1.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
34
275
1.26
0.57
2.3
2.5
kpa
4.1
4.4
0.35
34
263
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
239
0.74
0.56
1.1
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.0
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
91
1.44
0.53
1.3
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
48
408
1.20
0.52
2.7
4.7
ug/l
4.6
19.0
0.75
36
336
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
14
100
1.41
0.52
1.4
2.3
mg/l
14.8
12.3
0.93
14
91
(3019060) Gas panel - Arterial blood
26
206
1.28
0.52
4.0
5.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
47
399
1.20
0.52
1.2
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
351
3601
0.88
0.50
4.3
4.5
mmol/l
1.4
1.5
2.95
330
3319
(40768806) Pleura Pathology biopsy report
7
46
1.53
0.48
1.6
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
35
291
1.22
0.48
2.1
3.0
e9/l
71.1
71.0
0.00
27
222
(3015235) Bicarbonate [Moles/volume] in Capillary blood
13
94
1.39
0.46
1.3
2.9
mmol/l
25.3
25.5
0.09
13
83
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
15
198
0.75
0.46
1.5
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
155
1447
1.11
0.46
5.5
8.7
inr
1.2
1.2
0.18
38
418
(4034850)
8
121
0.65
0.46
2.1
9.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
85
0.58
0.45
1.2
1.1
—
9.8
—
0
11
(3008898) HLA-B27 [Presence]
15
112
1.35
0.45
1.2
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
59
519
1.16
0.45
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
202
1.25
0.44
1.1
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
95
1.38
0.44
1.5
1.4
ug/g
291.6
315.5
—
7
47
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
128
0.70
0.44
1.2
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15
113
1.34
0.43
3.9
3.4
ratio
5.1
2.6
—
5
11
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
15
113
1.34
0.43
3.9
3.6
mg/l
29.9
55.9
0.48
15
91
(3034860) Kappa light chains.free [Mass/volume] in Serum
15
113
1.34
0.43
3.9
3.6
mg/l
71.6
110.9
0.27
15
91
(3002032) Base excess in Venous blood by calculation
38
323
1.19
0.43
2.6
3.4
mmol/l
2.9
2.2
0.75
31
260
(3023410) Appearance of Cerebral spinal fluid
5
31
1.62
0.43
2.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
203
1.25
0.43
1.1
1.4
—
—
—
0
0
(4268621)
5
32
1.57
0.42
2.4
2.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
33
1.52
0.41
1.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
11.4
—
0.7
—
0
16
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.2
—
210.3
—
0
16
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
60
1.34
0.40
1.8
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
58
651
0.87
0.40
1.8
1.7
nmol/l
1232.3
1241.7
0.03
44
484
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
18
0.00
0.40
0.0
2.0
—
58.4
—
0
18
(3019225) pH of Specimen
28
334
0.83
0.40
2.5
4.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
61
1.32
0.39
1.1
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
142
1.28
0.39
2.2
3.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
115
1067
1.11
0.38
2.8
3.1
mg/l
2029.6
236.3
1.16
80
674
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
30
354
0.84
0.38
1.5
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
68
1.33
0.38
2.9
1.4
—
—
—
0
0
(3015736) pH of Urine
125
1334
0.91
0.36
3.1
3.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
90
1.34
0.36
1.2
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
108
1.31
0.35
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
108
1.31
0.35
1.1
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
308
0.83
0.35
2.0
2.7
ml/min/173m2
62.4
61.9
—
7
127
(44790049)
6
43
1.40
0.35
1.0
1.6
—
—
—
0
0
(44790048)
6
43
1.40
0.35
1.0
1.6
—
—
—
0
0
(44790047)
6
43
1.40
0.35
1.0
1.6
—
—
—
0
0
(44806118)
6
43
1.40
0.35
1.0
1.6
—
—
—
0
0
(4306422)
6
45
1.34
0.34
1.2
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
219
1.20
0.34
1.2
1.2
iu/ml
276.4
136.0
—
8
98
(3020961) Endomysium IgA Ab [Titer] in Serum
12
154
0.77
0.32
1.1
1.1
—
6.0
—
0
6
(42529406) Shigella sp [Presence] in Stool by Culture
14
110
1.28
0.32
1.1
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
44
391
1.14
0.31
2.0
2.7
%
2.1
1.8
0.79
39
351
(40761536) Microorganisms panel - Urine sediment
24
282
0.84
0.31
4.8
3.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
45
503
0.88
0.30
1.4
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
64
698
0.90
0.29
2.6
2.9
mmol/l
2.4
2.5
0.27
59
617
(3000764) Benzodiazepines [Presence] in Urine
8
65
1.23
0.27
1.1
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
65
1.23
0.27
1.1
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
66
1.22
0.27
1.1
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
66
1.22
0.27
1.1
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
45
407
1.12
0.25
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
120
1138
1.07
0.25
3.2
3.8
mg/mmol
7.6
7.4
0.03
76
703
(40761535) Cells panel - Urine sediment
25
287
0.86
0.25
3.6
3.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
96
1.26
0.24
1.2
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
39
351
1.12
0.24
1.2
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
240
2335
1.06
0.23
3.1
3.1
u/l
53.5
50.7
0.22
230
2170
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
347
3415
1.08
0.23
5.2
5.7
mmol/mol
39.4
39.9
0.56
327
3186
(40768795) Lymph node Pathology biopsy report
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
39
1.29
0.23
1.2
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
95
0.73
0.22
3.4
2.9
mg/l
1.7
1.6
—
7
84
(40768446) Kidney Pathology biopsy report
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
365
3696
0.93
0.21
4.9
5.0
mmol/l
2.7
2.8
0.88
344
3416
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.1
—
18.6
—
0
7
(3043410) Blood group antigens tested for on Red Blood Cells
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
8.3
—
0
13
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
116
1108
1.06
0.20
2.7
3.0
mmol/l
7.2
7.3
0.15
111
926
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
358
3626
0.93
0.20
4.5
4.5
mmol/l
4.6
4.7
2.09
338
3365
(3004451) EKG impression Narrative
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
14
0.00
0.20
0.0
1.1
—
294.1
—
0
8
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
13
108
1.21
0.20
2.2
2.0
%
93.2
91.1
0.12
13
100
(3017143) Hepatitis C virus Ab [Presence] in Serum
36
327
1.11
0.20
1.2
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
36
327
1.11
0.20
2.7
3.4
kpa
5.9
5.8
0.11
36
316
(3015377) Calcium [Moles/volume] in Serum or Plasma
129
1238
1.06
0.19
2.7
3.6
mmol/l
2.4
2.4
0.10
119
1081
(3007164) IgA [Mass/volume] in Serum or Plasma
69
648
1.08
0.19
1.4
1.4
g/l
2.6
2.6
0.05
38
406
(3028271) Lactate [Moles/volume] in Capillary blood
6
51
1.18
0.19
1.5
1.9
mmol/l
1.6
1.5
—
6
51
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
52
1.16
0.19
1.3
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
58
1.21
0.18
1.3
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
7
59
1.19
0.18
1.1
1.2
mmol/l
66.1
60.5
—
7
52
(3002256) Pathology report gross observation
51
475
1.08
0.18
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
423
0.91
0.17
6.7
6.9
—
—
—
0
0
(4035726)
32
350
0.91
0.17
1.2
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
31
283
1.10
0.16
8.2
7.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
78
0.77
0.15
1.0
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
6
79
0.76
0.15
3.2
3.7
mg/l
12.3
29.8
—
6
50
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
80
0.75
0.15
1.3
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
81
1.11
0.15
1.7
1.4
—
—
—
0
0
(3020891) Body temperature
11
129
0.85
0.15
1.8
3.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
170
0.88
0.14
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
148
0.87
0.12
1.3
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
104
1.16
0.12
1.8
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
41
433
0.94
0.10
1.1
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
44
1.14
0.10
4.6
2.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.4
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
48
1.04
0.09
1.0
3.5
—
1071.2
—
0
6
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
56
1.07
0.08
1.2
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
61
0.82
0.08
1.6
1.2
u/l
8.2
9.7
—
5
50
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
68
1.03
0.08
1.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
68
1.03
0.08
1.0
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
98
1.13
0.07
3.5
3.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
70
0.86
0.07
5.0
2.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
137
1.10
0.07
2.2
1.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
77
1.04
0.07
1.0
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
80
0.87
0.07
2.3
2.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
85
1.06
0.07
1.2
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
87
1.04
0.07
1.2
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
101
0.89
0.06
1.3
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
41
394
1.04
0.06
2.0
2.4
ug/g
118.5
131.3
0.15
36
318
(3007566) Smooth muscle Ab [Titer] in Serum
10
91
1.10
0.04
1.1
1.2
—
68.3
—
0
6
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
348
3494
0.98
0.03
3.9
4.0
mmol/l
1.4
1.3
1.24
328
3205
(3018405) Lactate [Moles/volume] in Arterial blood
11
118
0.93
0.03
1.8
3.7
mmol/l
1.0
1.4
1.71
11
112
(1002224) Polysomnography panel
15
142
1.06
0.02
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
36
369
0.97
0.02
3.8
3.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
173
0.98
0.00
1.2
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
129
1.01
0.00
2.3
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
69
692
1.00
0.00
2.6
2.7
mosm/kgh2o
548.3
555.6
0.08
63
592
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
1727.4
—
0
9
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4094501)
9
96
0.94
0.00
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
43.0
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
16.5
—
0
5
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
54.8
—
0
5
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
1.8
—
0
6
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
86
0.93
0.00
1.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
56
0.89
0.00
2.6
3.9
%
60.6
58.2
—
5
56
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
71
0.99
0.00
1.0
1.2
u/l
21.3
19.2
—
7
60
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
10.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
16.8
—
0
7
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.9
—
0
5
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
73
0.96
0.00
3.1
3.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
59
0.85
0.00
1.0
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
54
0.93
0.00
2.2
3.4
e9/l
4.1
4.6
—
5
54
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.0
—
12822.0
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint G6_LSROOT and mortality.

Females

Parameter HR [95% CI] p-value
G6_LSROOT 1.109 [0.93, 1.32] 0.251
Birth year 0.998 [0.99, 1.01] 0.698

During the follow-up period (1.1.1998 — 31.12.2019), 198 out of 1477 females with G6_LSROOT died.

Males

Parameter HR [95% CI] p-value
G6_LSROOT 1.121 [0.94, 1.34] 0.205
Birth year 0.989 [0.98, 1.0] 0.017

During the follow-up period (1.1.1998 — 31.12.2019), 241 out of 1304 males with G6_LSROOT died.

Mortality risk

Mortality risk for people of age

years, who have G6_LSROOT.

N-year risk Females Males
1 0.112% 0.173%
5 0.749% 1.307%
10 1.701% 3.452%
15 3.364% 6.466%
20 6.176% 10.951%

Relationships between endpoints

↥

Index endpoint: G6_LSROOT – Lumbosacral root disorders, not elsewhere classified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data